Senior Scientist, Early Clinical Scientist

Merck & Co. is looking for an experienced and ambitious Senior Scientist, Early Clinical Scientist to join our team. The ideal candidate will have a passion for developing innovative clinical protocols and strategies, and for driving the successful execution of clinical development programs. We are looking for someone who has an advanced degree in a scientific field, preferably in the area of pharmacology, toxicology, or drug development and more than five years of experience in the pharmaceutical industry.The Senior Scientist, Early Clinical Scientist will be responsible for leading and managing the clinical development programs for assigned compounds, providing scientific expertise and strategic guidance to the development team. They must have strong organizational and communication skills, as well as a commitment to excellence and the ability to work collaboratively in a fast-paced, dynamic environment. This is an excellent opportunity for someone who is eager to make an impact on the development of life-changing medicines. If you have the qualifications we seek and are looking to take the next step in your career, we want to hear from you.

According to JobzMall, the average salary range for a Senior Scientist, Early Clinical Scientist in Rahway, NJ 07065, USA is between $95,000 - $132,000 per year. This range may vary depending on the company and the individual's qualifications, experience, and skills.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.